Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH
Yatharth Hospital And Trauma Care Services — Q1 FY2025 Earnings Presentation
34 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, Aug 13, 2024
Slide 1: Exchange filing letter for Investor Presentation Q1 FY25
August 13, 2024 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 P J Towers, Dalal Street, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai -400001, India Mumbai – 400 051 Symbol: YATHARTH Scrip Code: 543
Slide 2: Q1 FY25 Earnings Presentation
Q1 FY25 Earnings Presentation Aug 13, 2024
Slide 3: Disclaimer
Disclaimer Certain matters discussed in this Presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements doesn’t guarantee future performance and are subject t
Slide 4: Q1 FY25 Performance Highlights
Q1 FY25 Performance Highlights
Slide 5: Q1 FY25 Performance Summary
Q1 FY25 Performance Summary Bed Capacity Revenue EBITDA EBITDA Margin 1,605 beds Rs. 2,118 mn Rs. 537 mn 25.3% +200 beds +37% YoY +30% YoY -146bps YoY PAT PAT Margin ROCE ROE Rs. 304 mn 14.3% 29%* 22%* +60% YoY +203bps YoY Total Cash Occupancy ARPOB ALOS Rs. 1,826 mn 61% Rs. 30,551 4.55 +10% YoY +9%
Slide 6: Robust Improvement in Financial Parameters
Robust Improvement in Financial Parameters Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 80 0 30% 795 790 27.8% 785 780 +37% YoY 775 29% 770 765 760 26.8% 26.6% 755 750 745 28% 26.2% 740 735 730 725 25.3% 720 27% 715 710 705 700 69 5 26% 69 0 68 5 68 0 675 670 66 5 25% 66 0 65 5 65 0 +19% QoQ 64 5 64 0 2
Slide 7: Healthy performances across operational metrics
Healthy performances across operational metrics IPD & OPD Volumes (in ‘000s) Occupancy (%) 61% IPD Volume OPD Volume 57% 57% 98 102 93 94 90 52% 51% 81 86 82 87 78 12 13 12 12 15 Q1FY24 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q1FY24 Q2FY24 Q3FY24 Q4FY24 Q1FY25 IPD & OPD Revenue (Rs mn) ARPOB (Rs.) IPD Revenue O
Slide 8: Diversifying revenues across hospitals
Diversifying revenues across hospitals Greater Greater Noida Noida Faridabad 36% 33% 1% Jhansi- Orchha Jhansi- 5% Orchha 5% Q1 FY24 Q1 FY25 Noida Extension Noida Noida Noida 23% Extension 29% 30% 38% Noida extension registers highest growth at 81% YoY, contributing 38% to Group’s revenue 7
Slide 9: Expanding high value specialties across hospitals
Expanding high value specialties across hospitals Diverse mix of specialties at all hospitals Noida extension hospital registered highest share of super specialties Q1 23% 11% 10% 9% 9% 8% 7% 6% 5% 4% 3% FY2025 Pediatrics Oncology Gynecology 4% 17% 6% Pulmonology Q1 33% 9% 3% 10% 10% 8% 5% 6% 6% FY2
Slide 10: Operational Highlights for the quarter
Operational Highlights for the quarter Improvement in occupancy across our hospitals Capacity Expansion, through greenfield as well brownfield opportunities • Occupancy levels improved to 61% in Q1 FY25, compared to 51% in Q1 FY24 • Faridabad hospital got operationalized on May 12, 2024, adding 200
Slide 11: Business highlights during the period
Business highlights during the period Clinical Achievements Other highlights ➢ Dr. Balkishan Gupta, Group Director Surgical Disciplines & Group Medical Advisor – Faridabad, received prestigious "Sushruta Award" from India News ➢ Dr. Jyoti Mishra, Director & HOD -OBGY receives Vaticutti award at ROBO
Slide 12: Profit & Loss Summary
Profit & Loss Summary Change Change Particulars (Rs Mn) Q1FY25 Q1FY24 Q4FY24 YoY QoQ Revenue from Operations 2,118 1,545 37% 1,778 19% Medical Consumables & Pharmacy items 468 281 67% 375 25% Employee Expenses 346 268 29% 319 9% Other Expenses 767 582 32% 619 24% EBITDA 537 414 30% 465 15% EBITDA Ma
Slide 13: At a Glance
At a Glance
Slide 14: Leading super specialty hospital in North India
Leading super specialty hospital in North India Among top 10 largest private hospitals of Delhi NCR region in terms of number of beds One-stop destination for patient needs providing all levels of 5 10 81% healthcare services from primary to tertiary Hospitals Center of Excellence Beds in Metros 201
Slide 15: Empowering Health, Enriching Lives
Empowering Health, Enriching Lives Our unwavering commitment to patient-centric care is supported by three strategic pillars To evolve as the most preferred destination for quality healthcare that provides a comprehensive range of services and is trusted for personalized care with compassion Clinici
Slide 16: Our Journey
Our Journey Growing presence across regions and services Established our first Expansion of our first Acquisition of 4th hospital - Acquired 5th hospital – hospital in Greater hospital, Greater Noida Jhansi Orchha hospital Asian Fidelis Hospital in Noida hospital, to 400 beds adding 305 beds, pursua
Slide 17: Our Hospitals
Our Hospitals Built on foundation of talent, trust, technology, service and infrastructure Diversified revenue mix across hospitals Greater Noida Jhansi - Hospitals Noida Noida Extension Orchha Faridabad Faridabad Jhansi- 1% Year of Operation 2010 2013 2019 2022 2024 Orchha 5% Greater Noida Beds Cap
Slide 18: Our Mature Hospitals
Our Mature Hospitals 67% Occupancy Provides a wide spectrum of super specialty services in the field of Greater Noida cardiology, cardiovascular and thoracic surgery, neurology, 35,047 ARPOB neurosurgery, urology, nephrology, oncology, gastroenterology etc. 2010 Incorporated 400 Beds; 112 ICU Beds S
Slide 19: Our New hospitals
Our New hospitals 45% Jhansi – Occupancy One of the largest hospital in Jhansi-Orchha-Gwalior region, has infrastructure to operate all the major super Orchha 10,839 specialties ARPOB 2022 Acquisition Acquired in FY22, aimed at further expanding into new 305 Beds; 76 ICU Beds geographies and growing
Slide 20: Proximity to international airports to fuel medical tourism
Proximity to international airports to fuel medical tourism India’s medical tourism industry has been growing ~45% of the international patients travel to Delhi-NCR 40% 7.0 Faridabad Noida Extension 6.4 (~68 km from Airport) 5.0 Noida 22% 4.8 (~56 km from Airport) 4.3 NH334DD 68 Km 3.0 2.3 11% 1.8 2
Slide 21: Delhi NCR market is poised for substantial expansion
Delhi NCR market is poised for substantial expansion Delhi NCR bed density is lower compared to other metros Patient influx from neighboring regions with lower density 43 40 36 33 30 27 23 22 21 13 12 11 11 8 MMR MP HP Pune Uttarakhand Haryana Rajasthan Bengaluru Delhi-NCR Chennai Hyderabad UP Ghazi
Slide 22: Yatharth is well positioned in most of the levers
Yatharth is well positioned in most of the levers Yatharth Apollo Max Fortis NH KIMS Jupiter Strategic Levers to improve competence No of beds Beds in ✓ Target to expand bed capacity Metros % to 2,800-3,000 beds by FY28 Revenue ✓ Increasing share of super 3Y CAGR specialties & introduction of oncolo
Slide 23: Core strategies driving growth
Core strategies driving growth Optimizing Infrastructure Enhancing occupancy and ARPOB across our hospitals 01 Capacity Addition 02 Greenfield and brownfield expansion Leverage Technology 03 Advanced and high-end medical equipment and technology 04 Clinical Expertise Attracting best talent to drive
Slide 24: Optimizing existing infrastructure
Optimizing existing infrastructure Mature hospitals New hospitals Total 63% Occupancy (%) 55% 54% 50% 50% 45% Improve 42% 42% Diversifying customer specialties service 23% 8% NM NM FY21 FY22 FY23 FY24 Our 5-fold approach to optimize 29,646 28,571 existing infra 26,886 26,538 Optimized Enhanced care
Slide 25: Capacity addition - greenfield and brownfield expansion
Capacity addition - greenfield and brownfield expansion Capacity addition trend and roadmap ahead Operational Beds New bed addition Planned bed addition Target bed capacity ~2,800-3,000 ~450 ~300-400 ~550-600 May-24 Apr-22 May-19 • Yatharth’s hospital in Greater Faridabad was operationalized on May
Slide 26: Advanced and high-end medical equipment and technology
Advanced and high-end medical equipment and technology • Hospitals are equipped with machines and devices with sophisticated technology • Strive to introduce cutting-edge medical technology and state-of-the-art equipment Complex Kidney, Liver & Bone Robotic Surgeries – Marrow Transplant DaVinci, Mak
Slide 27: Attracting best talent to drive super specialties
Attracting best talent to drive super specialties Strategic initiatives aimed to ease attrition Integrating talent from First mover advantage in well-established allied building out network across workforce Tier II/III cities ❑ Introduced DNB program across 8 specialties in 2 of the hospitals ❑ DNB
Slide 28: Proven record of consistent financial performance (1/2)
Proven record of consistent financial performance (1/2) Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 29.3% 2300 2295 30% 2290 2285 2280 2275 2270 2265 2260 2255 2250 27.6% 2245 2240 2235 2230 2225 2220 29% 2215 2210 2205 2200 219 219 5 0 26.8% 218 218 5 0 2175 2170 216 216 5 0 215 215 5 0 28% 214 214 5
Slide 29: Proven record of consistent financial performance (2/2)
Proven record of consistent financial performance (2/2) Return on capital employed (%) Return on equity (%) 29% 45% 44% 28% 27% 24% 22% 18% FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24 Gross Block (Rs mn) 130 Net Working Capital Days 0.27 125 0.26 Capex per bed 120 0.25 0.24 115 0.23 110 0.22 105 3.91 3.
Slide 30: Consistent performance across operational parameters
Consistent performance across operational parameters IPD/OPD Volume (in ‘000s) IPD/OPD Revenue (in ‘000s) IPD Volume OPD Volume IPD Revenue OPD Revenue 6,705 375 376 5,203 819 256 4,009 684 157 546 330 327 2,287 5,886 223 227 4,519 3,464 136 2,060 21 33 45 49 FY21 FY22 FY23 FY24 FY21 FY22 FY23 FY24
Slide 31: Strengthened balance sheet with IPO proceeds
Strengthened balance sheet with IPO proceeds Amt. Raised Utilisation Net Worth (Rs mn) 40% Debt Repayment 2,450 mn 99% 8,743 90 00 0.27 0.26 0.25 80 00 0.24 Organic Capex 1,326 mn 51% 0.23 0.22 7000 0.21 0.2 0.19 22% 60 00 0.18 0.17 0.16 Rs 6,100 mn 50 00 0.15 0.14 0.13 40 00 0.12 0.11 IPO Proceeds
Slide 32: Awards and Accreditations
Awards and Accreditations 2020 2021 2023 2024 ➢ Awarded 1st in Swachhta ➢ Covid Thank You award by Niva ➢ Awarded UP Ratan Samman by ➢ Awarded Best Brand for Ranking (for quarter ended Bupa Dainik Jagran Inext Excellence in Healthcare at Sep 2019) in Swachh ➢ 5-star grading by Infomerics ➢ Accredita
Slide 33: Experienced board and leadership team
Experienced board and leadership team Promila Bhardwaj Dr. Ajay Kumar Tyagi Independent Director Chairman & Whole-time Director 35+ yrs of experience 17+ yrs of experience Bachelor of arts, Master’s of arts in English, philosophy in social Bachelor of medicine, surgery, and diploma in orthopaedics s
Slide 34: Thank You
Thank You Yatharth Hospital & Trauma Care Services Ltd Investor Relations Contact Mr. Neeraj Vinayak, Head – Strategy and Investor Relations investor.relations@yatharthhospitals.com CIN: L85110DL2008PLC174706 www.yatharthhospitals.com
Yatharth Hospital and Trauma Care Services — Q1 FY2025 Earnings Presentation on 6ix